The global Glioblastoma Multiforme (GBM) treatment market is poised for significant growth and is expected to reach a valuation of USD 4.82 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.9% during the forecast period. This upward trajectory is driven by rising incidences of brain tumors, increasing awareness about GBM, advancements in therapeutic technologies,...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek